Roobirk and Antidote, two startup companies that work to empower people living with Alzheimer’s disease have entered a partnership with Galaxy, an online portal to initiatives that facilitate patient participation in Alzheimer’s research. More than 80% of clinical studies overall are delayed or closed because not enough patients meet enrollment requirements.
A treatment that uses microscopic droplets of fat – called nanoliposomes – to carry drugs to the brain has  been used effectively to target cancer cells. Now the technique has shown promise in restoring memory loss in mice models of Alzheimer’s disease, according to a new study funded by the Alzheimer’s…
Two physicians — one at the University of Pennsylvania’s Perelman School of Medicine and the other with the University of Michigan — argue in a recent opinion piece that the National Alzheimer Project Act (NAPA), as it now stands, has resulted in potential treatments for Alzheimer’s disease being tested without a…
A technique using light intensity to detect explosive residue in homemade bombs, also known as improvised explosive devices (IEDs), is now being used by researchers from the University of Adelaide in South Australia to identify vitamins in blood that are linked to Alzheimer’s disease and dementia. Vitamin B12 is…
Using laser technology, researchers have found that peptides related to Alzheimer’s Disease move at dangerous speeds prior to clumping or forming the plaques that characterize the disease. Moreover, the scientists also identified strategies to keep the blocks that form the proteins moving at safe speeds. The study, “Monomer Dynamics…
Researchers reviewed the novel mutations found in genes associated with early-onset Alzheimer’s disease in Asian countries, arguing that identifying disease-associated mutations greatly contributes to the knowledge of the cause and effect of the disease. This information is also essential to develop preventive and therapeutic strategies. The study, “Mutations, Associated With Early-Onset Alzheimer’s Disease, Discovered In…
Cure Alzheimer’s Fund, a Massachusetts-based nonprofit dedicated to funding promising research into ways to prevent, slow, or reverse Alzheimer’s disease, has awarded more than $700,000 in research grants in September to scientists working toward those goals. The five newly funded projects brings Cure Alzheimer’s research support for 2016 to more…
A new study by researchers at Rice University in Houston used computer simulations to explore the beginnings of the molecular process that marks the start of Alzheimer’s disease, which is triggered by the aggregation of a common protein called amyloid beta. The Rice investigators are the first to model the energy…
Researchers have successfully used a viral transport mechanism to deliver a gene to the brain of mice that prevented the development of Alzheimer’s disease (AD). The results could have a profound impact on the future of gene therapy in treating Alzheimer’s. These were the findings from a study conducted by researchers…
According to a new study, people who have brain deposits of another faulty protein called TDP-43, in addition to amyloid-beta and tau aggregates, have a much higher risk of developing Alzheimer’s disease than those having only plaques and tangles. The study, “TDP-43 stage, mixed pathologies, and clinical…
Get regular updates to your inbox.